Cartesian Therapeutics, Inc. Common Stock
Symbol: RNAC (NASDAQ)
8.99
▼ (-3.18%) -0.295
Company Description:
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
Key Stats
- Today's Open: $9.18
- Today's High: $9.475
- Today's Low: $8.75
- Today's Volume: 110.60K
- Yesterday Close: $9.28
- Yesterday High: $10.0863
- Yesterday Low: $9.23
- Yesterday Volume: 73.54K
- Last Min Volume: 80
- Last Min High: $8.985
- Last Min Low: $8.985
- Last Min VWAP: $8.985
Company Profile
- Name: Cartesian Therapeutics, Inc. Common Stock
- Website: https://www.cartesiantherapeutics.com
- Listed Date: 2016-06-22
- Location: FREDERICK, MD
- Market Status: Active
- CIK Number: 0001453687
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $241.30M
- Round Lot: 100
- Outstanding Shares: 26.00M
- Asset Type: CS
RECENT FILINGS FOR RNAC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 8-K | View |
| 2025-10-08 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-05-30 | 8-K | View |
| 2025-05-14 | 4 | View |
| 2025-05-08 | S-8 | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-04-29 | 8-K | View |
| 2025-04-28 | DEF 14A | View |
| 2025-04-28 | DEFA14A | View |
| 2025-04-25 | SCHEDULE 13G | View |
| 2025-04-16 | 4 | View |
| 2025-04-11 | 4 | View |
| 2025-04-08 | 8-K | View |
| 2025-03-20 | 4 | View |
| 2025-03-13 | 10-K | View |
| 2025-03-13 | 8-K | View |
Latest News on RNAC